National Institute of Mental Health: Side Effects Mild, Brief With Single Antidepressant Dose of Intravenous Ketamine
November 18, 2019
November 18, 2019
BETHESDA, Maryland, Nov. 18 -- The U.S. Department of Health and Human Services' National Institute of Mental Health issued the following news:
* * *
- Safety data analyzed from five NIH inpatient clinical trials
* * *
National Institutes of Health researchers found that a single, low-dose ketamine infusion was relatively free of side effects for patients with treatment-resistant depression. Elia Acevedo-Diaz, M.D., Carlos Zarate, M.D. (https:/ . . .
* * *
- Safety data analyzed from five NIH inpatient clinical trials
* * *
National Institutes of Health researchers found that a single, low-dose ketamine infusion was relatively free of side effects for patients with treatment-resistant depression. Elia Acevedo-Diaz, M.D., Carlos Zarate, M.D. (https:/ . . .